Sign in
8-K

Current Report

Allogene Therapeutics, Inc. Filed Acc 0001628280-26-044618

Shareholder vote results · Other events

  • Item 5.07 Submission of matters to a vote of security holders
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading allo-20260618.htm…